Article

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancer

2020-03-04

Abstract excerpt

<h4>Objective: </h4> Lung cancer is the leading cause of cancer-related death globally, and non-small cell lung cancer (NSCLC) is the most common type of lung cancer. However, the diagnosis and prognosis of NSCLC remain dim. Our team has focused on identifying differentially expressed genes (DEGs) between NSCLC tissues and adjacent tissues, which may be useful as effective diagnostic markers that can better explai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8071bb1b-36fb-58d2-9364-1dd81c859e37
DOI: 10.21203/rs.3.rs-16005/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerDOI 10.21203/rs.3.rs-16005/v1Read

PLEK2 and SCN7A: novel biomarkers of non-small cell lung cancerSemantic proximity Read

Identification and validation of key genes associated with non‐small‐cell lung cancerSemantic proximity Read

Comprehensive Analysis of Prognostic Value and Immune Infiltration of ATⅡ-associated Genes in Non-small Cell Lung CancerSemantic proximity Read

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung CancerSemantic proximity Read

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysisSemantic proximity Read

Identification of 10 Important Genes with Poor Prognosis in Non-small cell Lung Cancer through Bioinformatical AnalysisSemantic proximity Read

Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and TreatmentsSemantic proximity Read

Analysis of the effect of NEKs on the prognosis of patients with Non-small-cell lung carcinoma based on bioinformaticsSemantic proximity Read

Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.Semantic proximity Read

Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancerSemantic proximity Read

Analysis of the effect of NEKs on the prognosis of patients with non-small-cell lung carcinoma based on bioinformatics.Semantic proximity Read

PLEK2 activates the PI3K/AKT signaling pathway to drive lung adenocarcinoma progression by upregulating SPC25Semantic proximity Read